Extremity
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma （SPARE-02） (NCT05235100) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-09-01 |
| Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01） (NCT05167994) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2020-05-01 |
Track Extremity automatically
Every clearance here is in the API, with alerts when new ones post.